Associations between erythropoietin resistance and iron metabolism markers in patients undergoing extended-hours and conventional hemodialysis
Open Access
- 19 September 2026
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- p. 1-10
Abstract
Background: Extended-hours hemodialysis, defined as ≥6 h/session, three or four times per week, has been associated with lower erythropoietin resistance index (ERI), although the biological mechanisms remain unclear. We aimed to compare the associations between ERI and iron metabolism markers in patients undergoing extended-hours versus conventional hemodialysis. Methods: We included patients who received either extended-hours or conventional hemodialysis between January and March 2020. The ERI was calculated by dividing the weekly erythropoiesis-stimulating agent (ESA) dose, expressed as epoetin equivalents divided by body weight and hemoglobin level. Linear and non-linear associations were evaluated using multivariable linear regression and restricted cubic spline (RCS) analyses. Results: We analyzed 366 patients (178 receiving extended-hours hemodialysis and 188 receiving conventional hemodialysis). Hemoglobin levels were 10.9 and 11.2 g/dL, median ferritin levels were 34.8 and 63.6 ng/mL, and median transferrin saturation (TSAT) values were 16.9% and 20.5%, respectively. Extended-hours hemodialysis was associated with a lower ERI after multivariable adjustment (coefficient, −4.49 IU/kg/week per g/dL; 95% confidence interval, −6.76 to −2.22). In the RCS analysis, ERI increased with decreasing ferritin levels in the conventional hemodialysis group, whereas no increase was observed at lower ferritin levels in the extended-hours group. A similar trend was observed with respect to TSAT. Conclusions: Extended-hours hemodialysis was associated with lower ERI. Exploratory RCS analyses suggested potential modality-related differences in the relationships between ERI and ferritin or TSAT. These findings suggest that the association between iron status and ESA responsiveness may differ by dialysis modality and warrants further investigation.Keywords
Funding Information
- Nagoya University
This publication has 37 references indexed in Scilit:
- KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Kidney International, 2026
- Longitudinal impact of extended-hours hemodialysis with a liberalized diet on nutritional status and survival outcomes: findings from the LIBERTY cohortClinical and Experimental Nephrology, 2025
- Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational StudyAdvances in Therapy, 2024
- Essential points from evidence-based clinical practice guideline for chronic kidney disease 2023Clinical and Experimental Nephrology, 2024
- Paper-Based Analytical Devices for Accurate Assessment of Transferrin Saturation in Diagnosed Clinical Samples from Ischemic Stroke PatientsAnalytical Chemistry, 2023
- In-Center Nocturnal Hemodialysis Versus Conventional Hemodialysis: A Systematic Review of the EvidenceAmerican Journal of Kidney Diseases, 2017
- Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM StudyAdvances in Therapy, 2013
- Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietinInternational Urology and Nephrology, 2013
- Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in JapanAmerican Journal of Kidney Diseases, 2012
- The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialKidney International, 2011